Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brandie Metz

Pediatric Dermatology Irvine, CA Medical Doctor

NPI 1639105463 CMS profile 164958

3500 Barranca Pkwy, Suite 160, Irvine, CA 92606

Open in the dashboard

General payments

$41,263

360 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Brandie Metz of Irvine, CA is reported in the CMS Open Payments database as having received $41,263 across 360 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Pediatric Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,579 98
2024 General $11,050 82
2023 General $1,000 47
2022 General $1,920 52
2021 General $553 22
2020 General $12,237 23
2019 General $924 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brandie Metz
  • Pediatric Dermatology median
  • Middle half of Pediatric Dermatology
  • National median

In program year 2025, general payments to Brandie Metz were reported at $13,579. Among 172 Pediatric Dermatology profiles paid that year, the median was $302 and the middle half received between $110 and $2,128.

Show as a table
Year Brandie Metz Pediatric Dermatology median Middle half National median
2019 $924 $280 $89–$1,853 $163
2020 $12,237 $263 $71–$2,376 $114
2021 $553 $227 $69–$1,800 $132
2022 $1,920 $289 $69–$1,516 $149
2023 $1,000 $537 $114–$3,255 $160
2024 $11,050 $437 $114–$2,693 $164
2025 $13,579 $302 $110–$2,128 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organon LLC $11,961 17 payments
  2. Pfizer Inc. $10,146 47 payments
  3. Regeneron Pharmaceuticals, Inc. $9,457 11 payments
  4. Genzyme Corporation $4,578 40 payments
  5. Regeneron Healthcare Solutions, Inc. $950 37 payments
  6. AbbVie, Inc. $780 32 payments
  7. Galderma Laboratories, L.P. $488 19 payments
  8. Lilly USA, LLC $449 27 payments
  9. Arcutis Biotherapeutics, Inc. $409 29 payments
  10. Incyte Corporation $351 20 payments
  11. Other $1,696 81 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $14,441 5 payments
  2. Honoraria $10,200 3 payments
  3. Food and Beverage $7,674 331 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,725 1 payment
  5. Travel and Lodging $3,964 15 payments
  6. Education $259 5 payments
Products named General payments · program years 2019–2025
  1. VTAMA $11,989 18 payments
  2. DUPIXENT Inflammation And Immunology $10,152 34 payments
  3. CIBINQO $7,649 40 payments
  4. DUPIXENT Immunology $4,661 40 payments
  5. LITFULO $2,873 27 payments
  6. RINVOQ $754 31 payments
  7. TALTZ $449 27 payments
  8. Zoryve $364 27 payments
  9. OPZELURA $351 20 payments
  10. EUCRISA $275 16 payments
  11. Other $3,060 156 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

360 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Dermatology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record